CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 200 enrolled
Drug / intervention
Hidroferol® (ES) +2 moredrug
Likely dose
Hidroferol® (ES) 24000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01017354
NCT01017354Phase 2Completed
CompareCT.gov

Monthly Vitamin D to Improve Vitamin D Status and Maintain Function in Pre-frail Older Individuals Living at Home

University of Zurich·interventional·Posted Nov 20, 2009·Updated Aug 24, 2015

In Brief

A Phase 2 clinical trial evaluating Hidroferol® (ES) and ViDe3 (CH) for Community-dwelling Seniors and History of a Fall in the Previous 12 Months. Completed, enrolled 200 participants across 1 site.

Detailed Summary

This project was designed to optimizing vitamin D status in prefrail seniors age 70+ living at home and prevent their functional decline. We test 3 arms of monthly vitamin D supplementation. Intermittent dosing will improve adherence and simplify vitamin D supplementation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommunity-dwelling Seniors, History of a Fall in the Previous 12 Months
CountriesSwitzerland
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 20, 2009
Enrollment StartJan 1, 2010
Primary CompletionNov 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.6 years ago

Interventions

Hidroferol® (ES)drug

24000 IU vitamin D3 orally and once per month plus 300 mcg 25(OH)D orally and once per month

ViDe3 (CH)dietary

60000 vitamin D3 orally and once per month

ViDe3 (CH)dietary

24000 Vitamin D3 orally and once per month